Autologous CD19-Targeting CAR T Cells in a Patient With Refractory Juvenile Dermatomyositis.

This patient with JDM with severe chronic disease, refractory to multiple treatments, achieved sustained B cell depletion and ongoing immunosuppressive drug-free clinical and radiologic improvement eight months after a single infusion of anti-CD19 CAR T cells.